Symposium on AI & Medicine
You are invited to register for the second Symposium on AI & Medicine: Promises and Limits, occurring October 20, 2022, 8:00am-1:30pm EDT / 2:00pm-7:30pm CEST.
The MIT Computer Science and Artificial Intelligence Lab (CSAIL), the MIT Institute for Medical Engineering and Science (IMES), The French National Academy of Medicine, and the Health Data Hub are jointly organizing the symposium.
Clinicians and experts at the crossroads of AI and medicine from the United States and France will come together to jointly discuss topics that can facilitate collaboration and help better understand approaches on both sides of the Atlantic. The goal is also to better understand the possibilities and realities of AI, as well as the needs of patients.
The symposium will convene in person in France, and also via live stream. Please see the event website for agenda and to register, https://www.health-data-hub.fr/2nd-symposium-mit-hdh-academie-nationale-de-mecine
14:00 CEST - Welcome address by Patrice Tran Ba Huy, President of the Académie Nationale de
Médecine
14:10 CEST - Opening
Bernard Nordlinger, President of the Committee for Digital Medicine, Académie Nationale de
Médecine
Daniela Rus, Director of the CSAIL, MIT, Deputy Dean of Research at the Schwarzman College
of Computing, MIT
14:15 CEST - Session 1 : Access to health data at a national and international level
Emmanuel Bacry (moderator), Chief Scientific Officer of the Health Data Hub
Leo Anthony Celi, Principal Research Scientist at MIT, Associate Professor of Harvard Medical
School, Instructor at Harvard T.H. Chan School of Public Health
Hervé Delingette, Research Director Inria & 3IA Côte d'Azur
Andrzej Rys, Director for Health Systems and Products at the European Commission
Irene Schluender, Lawyer, BBMRI
15:30 CEST - Session 2 : Challenges for AI in medicine
PROGRAMME
Daniela Rus (moderator), MIT, CSAIL
Corinne Collignon, Head of Department, Digital Health Mission, Haute Autorité de Santé
Michel Dumontier, Distinguished Professor of Data Science at Maastricht University
Marc Julien, Co-CEO and COO at Diabeloop
Nancy Miller Rich, Chairman of Biotheryx, Director at Intercept Pharma, Alderyra Pharma,
Attralus Therapeutics, 4DMT and a founder and advisor to Ten63
Farhad Rikhtegar Nezami, Lead Investigator at Brigham and Women’s Hospital and Faculty
Member, Department of Surgery, Harvard Medical School
17:00 CEST - Break
17:30 CEST - Session 3 : How can medicine benefit from AI?
Elazer R. Edelman (moderator), Director of the IMES, MIT, Edward J. Poitras Professor in Medical
Engineering and Science at MIT, Professor of Medicine at Harvard Medical School
Bernard Nordlinger (moderator), Académie Nationale de Médecine
PANEL 1 : Drug discovery
Leo Anthony Celi, MIT, Harvard Medical School, T.H. Chan School of Public Health
Nicolas Do Huu, Co-founder and Chief AI Officer at Iktos
Farhad Rikhtegar Nezami, Brigham and Women's Hospital, Harvard Medical School
PANEL 1 : Drug discovery
Leo Anthony Celi, MIT, Harvard Medical School, Harvard T.H. Chan School of Public Health
PANEL 2 : Clinical trials, what clinicians need
Stéphanie Allassonnière, Professor and Vice-President Valorisation at University Paris Cité, Chaire
PR[AI]RIE at Institut PR[AI]RIE, Associate Professor at Ecole Polytechnique
Jean-Yves Blay, Head of Department of the Léon Bérard Center, President of UNICANCER
Ozanan Meireles, Director of the Surgical Artificial Intelligence and Innovation Laboratory at
Massachusetts General Hospital, Assistant Professor of Surgery at Massachusetts General
Hospital and Harvard Medical School
Leo Anthony Celi, MIT, Harvard Medical School, Harvard T.H. Chan School of Public Health
PANEL 3 : Human computer interaction
Bernard Bioulac, Professor emeritus at the University of Bordeaux, former deputy chief scientific
officer in charge of neurosciences at the Institute of Biological Sciences of the CNRS, member of
the National Academy of Medicine
Ozanan Meireles, Massachusetts General Hospital, Harvard Medical School
Blaise Yvert, Inserm Research Director at Institute of Neuroscience of Grenoble
19:15 CEST - Summation of the Symposium
The MIT Computer Science and Artificial Intelligence Lab (CSAIL), the MIT Institute for Medical Engineering and Science (IMES), The French National Academy of Medicine, and the Health Data Hub are jointly organizing the symposium.
Clinicians and experts at the crossroads of AI and medicine from the United States and France will come together to jointly discuss topics that can facilitate collaboration and help better understand approaches on both sides of the Atlantic. The goal is also to better understand the possibilities and realities of AI, as well as the needs of patients.
The symposium will convene in person in France, and also via live stream. Please see the event website for agenda and to register, https://www.health-data-hub.fr/2nd-symposium-mit-hdh-academie-nationale-de-mecine
14:00 CEST - Welcome address by Patrice Tran Ba Huy, President of the Académie Nationale de
Médecine
14:10 CEST - Opening
Bernard Nordlinger, President of the Committee for Digital Medicine, Académie Nationale de
Médecine
Daniela Rus, Director of the CSAIL, MIT, Deputy Dean of Research at the Schwarzman College
of Computing, MIT
14:15 CEST - Session 1 : Access to health data at a national and international level
Emmanuel Bacry (moderator), Chief Scientific Officer of the Health Data Hub
Leo Anthony Celi, Principal Research Scientist at MIT, Associate Professor of Harvard Medical
School, Instructor at Harvard T.H. Chan School of Public Health
Hervé Delingette, Research Director Inria & 3IA Côte d'Azur
Andrzej Rys, Director for Health Systems and Products at the European Commission
Irene Schluender, Lawyer, BBMRI
15:30 CEST - Session 2 : Challenges for AI in medicine
PROGRAMME
Daniela Rus (moderator), MIT, CSAIL
Corinne Collignon, Head of Department, Digital Health Mission, Haute Autorité de Santé
Michel Dumontier, Distinguished Professor of Data Science at Maastricht University
Marc Julien, Co-CEO and COO at Diabeloop
Nancy Miller Rich, Chairman of Biotheryx, Director at Intercept Pharma, Alderyra Pharma,
Attralus Therapeutics, 4DMT and a founder and advisor to Ten63
Farhad Rikhtegar Nezami, Lead Investigator at Brigham and Women’s Hospital and Faculty
Member, Department of Surgery, Harvard Medical School
17:00 CEST - Break
17:30 CEST - Session 3 : How can medicine benefit from AI?
Elazer R. Edelman (moderator), Director of the IMES, MIT, Edward J. Poitras Professor in Medical
Engineering and Science at MIT, Professor of Medicine at Harvard Medical School
Bernard Nordlinger (moderator), Académie Nationale de Médecine
PANEL 1 : Drug discovery
Leo Anthony Celi, MIT, Harvard Medical School, T.H. Chan School of Public Health
Nicolas Do Huu, Co-founder and Chief AI Officer at Iktos
Farhad Rikhtegar Nezami, Brigham and Women's Hospital, Harvard Medical School
PANEL 1 : Drug discovery
Leo Anthony Celi, MIT, Harvard Medical School, Harvard T.H. Chan School of Public Health
PANEL 2 : Clinical trials, what clinicians need
Stéphanie Allassonnière, Professor and Vice-President Valorisation at University Paris Cité, Chaire
PR[AI]RIE at Institut PR[AI]RIE, Associate Professor at Ecole Polytechnique
Jean-Yves Blay, Head of Department of the Léon Bérard Center, President of UNICANCER
Ozanan Meireles, Director of the Surgical Artificial Intelligence and Innovation Laboratory at
Massachusetts General Hospital, Assistant Professor of Surgery at Massachusetts General
Hospital and Harvard Medical School
Leo Anthony Celi, MIT, Harvard Medical School, Harvard T.H. Chan School of Public Health
PANEL 3 : Human computer interaction
Bernard Bioulac, Professor emeritus at the University of Bordeaux, former deputy chief scientific
officer in charge of neurosciences at the Institute of Biological Sciences of the CNRS, member of
the National Academy of Medicine
Ozanan Meireles, Massachusetts General Hospital, Harvard Medical School
Blaise Yvert, Inserm Research Director at Institute of Neuroscience of Grenoble
19:15 CEST - Summation of the Symposium